Examination Report |
1 | TM-1 | 16 Apr 2014 |
10 | Letters related to PRAS | 01 Oct 2018 |
11 | Certificate | 10 Oct 2018 |
2 | Power of Attorney | 16 Apr 2014 |
3 | Reply to Exam Report (MIS-R) | 04 Oct 2015 |
4 | TM-16 | 07 Feb 2017 |
5 | Letters related to PRAS | 08 Aug 2017 |
6 | Letters related to PRAS | 08 Aug 2017 |
7 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 12 Mar 2018 |
8 | Authorization Letter | 14 Mar 2018 |
9 | Journal Copy | 18 Jul 2018 |
1 | Hearing Notice (Show Cause) | 5847937 | 2640887 | 07 Feb 2018 |
2 | Hearing Notice (Adjourned) | 6215017 | 2816269 | 12 Apr 2018 |
3 | Tribunal Accepted Notice for : 2719272 | 6373931 | 2811865 | 18 May 2018 |
4 | O3 NOTICE | 17096752 | 6524333 | 10 Jan 2024 |
As per IP India data the trademark was applied on 16 April 2014.
ABBOTT HEALTHCARE applied for Mylol.
Listed class of trademark Mylol is 5.
Mylol is on the Registered stage of the trademark process.
Serial Number provided to trademark application is 2719272
Trademark application was filed by the following attorney agent:
Zeusip
The trademark is categorized as WORD.